Bridgeway Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

Bridgeway Capital Management’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,340	Closed	-$40K	–	1271
2021 Q3	$40K	Buy	+3,340	New	+$45.2K	﹤0.01%	1275
2021 Q2	–	Sell	-63,000	Closed	-$1.51M	–	1343
2021 Q1	$1.51M	Buy	63,000 +42,480	+207%	+$1.19M	0.03%	715
2020 Q4	$605K	Hold	20,520	–	–	0.01%	881
2020 Q3	$314K	Hold	20,520	–	–	0.01%	1045
2020 Q2	$513K	Buy	20,520 +6,110	+42%	+$133K	0.01%	849
2020 Q1	$294K	Buy	+14,410	New	+$344K	0.01%	934

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bridgeway Capital Management's CASI Position: Q4 2021 in Review

Bridgeway Capital Management sold out of CASI Pharmaceuticals (CASI) in Q4 2021, closing a stake of 3,340 shares — an estimated $40K sold.

Bridgeway Capital Management first reported a position in CASI in Q1 2020 and held it in 6 quarters. The position peaked at $1.51M in Q1 2021. 51 funds tracked by Wall St. Rank hold CASI as of Q4 2021.

Bridgeway Capital Management reported no remaining CASI Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Bridgeway Capital Management sold 3,340 CASI Pharmaceuticals shares in Q4 2021, an estimated $40K.
Bridgeway Capital Management first reported a position in CASI Pharmaceuticals in Q1 2020 and held it in 6 quarters.
Bridgeway Capital Management's CASI Pharmaceuticals position peaked at $1.51M in Q1 2021.
51 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2021.

Based on Bridgeway Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.